Hanmi Pharm. Co., Ltd. (KRX:128940)

South Korea · Delayed Price · Currency is KRW

480,500

-53,500 (-10.02%)

At close: Oct 8, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Reconciliation of Inter-Sector Transactions	-92.77B	-113.14B	-114.82B	-101.69B	-89.72B
Overseas Pharmaceuticals	402.40B	385.63B	397.69B	350.64B	288.73B
Active Pharmaceutical Ingredients	91.28B	108.89B	111.07B	100.55B	87.16B
Medicine	1.15T	1.11T	1.10T	982.05B	917.02B
Total	1.55T	1.50T	1.49T	1.33T	1.20T

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Republic of Korea	947.03B	918.60B	890.76B	826.08B	768.94B
China	405.75B	391.93B	404.85B	356.11B	321.56B
Japan	22.17B	56.13B	51.81B	44.80B	41.13B
Other	90.34B	77.96B	75.48B	63.69B	44.14B
The United States of America	82.24B	50.88B	67.99B	40.87B	27.43B
Total	1.55T	1.50T	1.49T	1.33T	1.20T